About Kendall Mohler
Form D filings for Automera US in 2023 list Kendall Mohler as executive officer.
Form D filings also name Kendall Mohler as an executive officer and director at KayoThera.
Kendall Mohler reports to the SEC as an officer of 2 public companies: ALSP Orchid Acquisition Corp I (ALOR) and Trubion Pharmaceuticals (TRBN).
Kendall Mohler first appears on SEC filings in 2008.
Experience
This experience comes from SEC filings. The years are when the filings name Kendall Mohler in the role, so the role may have started earlier or lasted longer.
Automera US Inc.
Executive officer
2023 · Seattle, WA
Develops potential cancer treatments using drug discovery tools and targeted protein degradation.
AI
ALSP Orchid Acquisition Corp I
Chief Development Officer
2021 · Public company (ALOR)
TI
Trubion Pharmaceuticals, Inc
SVP & Chief Scientific Officer
2008 – 2010 · Public company (TRBN)
Key Colleagues at Startups
The people Kendall Mohler works with at each company, as listed on that company's latest Form D.
Automera US Inc. · Form D, Sep 27, 2023
BW
Benjamin Zian-Loong Wang
Director
IH
Ian Howes
Executive officer and promoter
TL
Thong Le
Chief Executive Officer and director
SR
Suzanne Rettenmier
Executive officer
YC
Yu-Chieh Alice Chen
Director
WH
Wen Qi Ho
Director
KayoThera, Inc. · Form D/A, Jul 13, 2023
TL
Thong Le
Chief Executive Officer and director
ME
Mark Esposito
Executive officer and director
IH
Ian Howes
Executive officer